Immunophenotypic pattern of myeloid populations by flow cytometry analysis

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Accurate immunophenotypic characterization is essential for differentiating benign from malignant myeloid populations.
• Distinguishing specific myeloid cell types, including eosinophils, dysplastic granulocytes, neoplastic promyelocytes, and monocytes, presents diagnostic challenges.
• Flow cytometry (FC) provides critical data for myeloid cell identification and classification.

Purpose of the Study:

• To present immunophenotypic characteristics of benign and malignant myeloid cells.
• To emphasize differential diagnostic strategies, particularly for eosinophils, dysplastic granulocytes, neoplastic promyelocytes, and monocytes.
• To describe distinct flow cytometry patterns observed in acute promyelocytic leukemia (APL).

Main Methods:

• Analysis of immunophenotypic markers using flow cytometry (FC).
• Detailed examination of cell scatter properties (SSC, FSC) and marker expression (CD antigens, HLA-DR).
• Comparison of marker profiles for various myeloid cell types and leukemic blasts.

Main Results:

• Established characteristic marker profiles for eosinophils (e.g., CD45 bright, CD11b+, CD14-) and mature monocytes (e.g., CD11b+, CD14+, CD64+).
• Defined immunophenotypes for acute myeloid leukemia (AML) blasts (e.g., CD34+, CD117+, CD13+, CD33+) and four distinct FC patterns in acute promyelocytic leukemia (APL).
• Highlighted differences between classical (hypergranular) and hypogranular (microgranular) APL variants based on SSC and marker coexpression (e.g., CD2, CD34).

Conclusions:

• Immunophenotyping provides a robust method for distinguishing benign and malignant myeloid cells.
• Specific FC patterns and marker combinations are crucial for diagnosing APL subtypes and differentiating from other myeloid disorders.
• Detailed phenotypic analysis aids in the accurate diagnosis and classification of myeloid malignancies.